Invention Grant
- Patent Title: Recombinant MVA virus
- Patent Title (中): 重组MVA病毒
-
Application No.: US11522889Application Date: 2006-09-19
-
Publication No.: US08153138B2Publication Date: 2012-04-10
- Inventor: Gerd Sutter , Marion Ohlmann , Volker Erfle
- Applicant: Gerd Sutter , Marion Ohlmann , Volker Erfle
- Applicant Address: DE Oberschleissheim
- Assignee: GSF-Forschungszentrum fur Umwelt und Gesundheit GmbH
- Current Assignee: GSF-Forschungszentrum fur Umwelt und Gesundheit GmbH
- Current Assignee Address: DE Oberschleissheim
- Agency: Law Office of Salvatore Arrigo and Scott Lee, LLP
- Priority: DK0782/95 19950704
- Main IPC: A61K39/12
- IPC: A61K39/12
Abstract:
The present invention relates to recombinant vaccinia viruses derived from the modified vaccinia virus Ankara (MVA) and containing and capable of expressing foreign genes which are inserted at the site of a naturally occurring deletion in the MVA genome, and the use of such recombinant MVA viruses for the production of polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy, and the use of such recombinant MVA viruses encoding antigens as vaccines.
Public/Granted literature
- US20100266630A1 Recombinant MVA virus, and the use thereof Public/Granted day:2010-10-21
Information query
